Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma
Median Duration of Response Not Reached at 17.0 Months of Median Study Follow Up in C-144-01 StudyOral Presentation to Include Additional […]
Immunomedics to Present New Trodelvy™ Data In Non-Breast Cancer Indications at the 2020 ASCO Virtual Meeting
MORRIS PLAINS, N.J., May 13, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]
TSX News -
TSX Symbol: ZAR Zargon Oil & Gas Ltd. Announces Delay of Release of First Quarter Results and Shut In of Production
CALGARY, Alberta, May 13, 2020 (GLOBE NEWSWIRE) — Zargon Oil & Gas Ltd. (“Zargon” or the “Company”) announces that it […]
Flexion Therapeutics to Present at the RBC Capital Markets 2020 Virtual Global Healthcare Conference
BURLINGTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and […]
Kura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific Program
SAN DIEGO, May 13, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing […]
SMTC Corporation to Participate in the 17th Annual Craig-Hallum Institutional Investor Conference on May 27
TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — SMTC Corporation (Nasdaq:SMTX), a global electronics manufacturing services provider and winner of the […]
iCAD Presents Positive New Clinical Data for Xoft Brain IORT at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
Promising clinical research supports Xoft brain IORT as a viable treatment option for glioblastoma multiforme that may extend patients’ livesOverall […]
Atreca Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
SOUTH SAN FRANCISCO, Calif., May 13, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused […]
Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting
HOUSTON, May 13, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal […]
American Society of Clinical Oncology (ASCO) Abstract Reports Initial ALLO-501 ALPHA Phase 1 Data in Relapsed/Refractory Non-Hodgkin Lymphoma
ALLO-501 in Combination with ALLO-647 Based Lymphodepletion Regimen was Well Tolerated With No Dose-Limiting Toxicities or Evidence of Graft-vs-Host DiseaseAbstract […]
